Refine by
Drug Identification Articles & Analysis: Older
27 articles found
Additionally, these cell lines serve as a powerful tool for drug screening, enabling the identification of potential therapeutics for kidney diseases. ...
Preclinical drug discovery represents a critical phase in the development of new therapeutics. ...
Additionally, in silico screening techniques, such as molecular docking, have become invaluable tools in predicting how potential drugs may interact with nuclear receptors at a molecular level. These computational methods can significantly reduce the time and resources needed in the early stages of drug development. ...
Identification of Drug StereochemistryMany drug molecules are chiral, and their activity, metabolism, and toxicity can significantly differ due to stereochemistry. ...
However, one of the challenges faced in developing small molecule drugs to treat brain cancer is the blood-brain barrier, a protective barrier that prevents many drugs from reaching their targets in the brain. Researchers are still investigating strategies to overcome this barrier, similar to the use of nanoparticles or other drug delivery ...
The cells can be used as model systems in phenotypic and drug screening, high content analysis, target identification, drug development, toxicology testing, gene editing studies, reporter assays. ...
Excitingly, recent advancements in gene engineering and drug R&D have led to the development of rare disease gene therapy and small-molecule drugs. ...
Alongside the drug-target relationship, the analysis of the drug-disease relationship is equally important. ...
One critical element in the drug development process is drug metabolism and pharmacokinetics (DMPK), which refers to how a drug is absorbed, distributed, metabolized, and excreted (ADME) from the body. ...
It is also increasingly applied in drug development. FC not only can detect intracellular and extracellular components, but also detect soluble analytes in serum or plasma samples, such as cytokines, drug complexes, or anti-drug antibodies (ADA). ...
For instance, altered metabolite profiles have been associated with cancer, diabetes, cardiovascular diseases, and neurodegenerative disorders. Uncover Drug Targets: Metabolomics aids in the identification of potential therapeutic targets by highlighting specific metabolites or metabolic pathways that are dysregulated in diseases. ...
Ribo-seq technology finds its applications across a diverse spectrum of fields within life sciences, including: (1) Gene Regulation Studies: Ribo-seq empowers researchers to delve deep into the intricate web of gene regulation by pinpointing the direct influence of transcription factors and miRNAs on gene expression at the translation level. (2) Drug Development: CD ...
One critical element in the drug development process is drug metabolism and pharmacokinetics (DMPK), which refers to how a drug is absorbed, distributed, metabolized, and excreted (ADME) from the body. ...
Introduction of Drug Affinity Responsive Target Stability (DARTS) Drug target protein identification is an important step in the research and development of new drugs. Drug Affinity Response Target Stability (DARTS) is a technique that can rapidly and directly identify potential target proteins of small molecule ...
In the dynamic realm of drug discovery, the pursuit of innovative and effective treatments for diverse diseases demands groundbreaking approaches that can expedite the drug development lifecycle. ...
One of the significant advantages of scRNA-seq in drug discovery is its impact on target identification. By allowing researchers to dissect complex tissues and diseases at the cellular level, scRNA-seq enables the identification of distinct cell subtypes and their gene expression profiles. ...
Advantages of Single-Cell RNA Sequencing in Drug Discovery Single-Cell RNA Sequencing (scRNA-seq) offers several advantages in drug discovery, primarily through target identification. ...
We have identified the regulatory pathways to obtain Rx Drug Identification Numbers (DINs) in Canada and the USA for Epilepsy rare neurological conditions. ...
About: CanaQuest Medical is an award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder “PTSD,” including ...
Predicting and developing novel drug targets and biomarkers by cancer bioinformatics improves the speed and targeting ability of new therapies and drug development. ...